Cybeats Technologies Corp. announced a new software licence agreement with a top 3 global medical device and diagnostics leader, for Cybeats' SBOM Studio, to manage their Software Bill of Materials (SBOM) and support regulatory compliance requirements with looming FDA mandates on SBOM adoption for medical device manufacturers. This agreement will see SBOM Studio deployed by the maker of some of the world's most frequently used medical devices, spanning across multiple specialty domains ranging from orthopedics and ophthalmology to cardiology and sports medicine.

The signing of this agreement follows the Company's recent announcements surrounding the active scaling of its commercial activities in the medical devices sector to help organizations meet the recently announced FDA mandate that set a 90-day deadline for medical device companies to comply with new SBOM regulations. This engagement commencing on January 13th 2023, comes amidst a growing concern surrounding software supply chain security in the healthcare industry and the rapid sector-wide shift towards widespread SBOM adoption to enhance the security of connected medical devices and protect patient data, while ensuring the safe and reliable operation of these devices.